Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506

Gaetano Ciancio*, George W. Burke, David Roth, Joshua Miller

*Corresponding author for this work

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Most recipients of simultaneous pancreas-kidney transplants experience acute rejection in the early postoperative course. We report our experience with four recipients of simultaneous pancreas-kidney transplants with acute rejection who were effectively treated with the combination of intravenous and oral FK506 therapy. This spared these patients an extra course of monoclonal or polyclonal antibody.

Original languageEnglish (US)
Pages (from-to)785-788
Number of pages4
JournalTransplantation
Volume63
Issue number5
DOIs
StatePublished - Mar 15 1997

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Fingerprint Dive into the research topics of 'Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506'. Together they form a unique fingerprint.

  • Cite this